BOLT BIOTHERAPEUTICS INC (BOLT)

US0977021049 - Common Stock

1.12  +0.01 (+0.9%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
7.88M5.73M1.26M230.00K220.00K
Operating Expenses
84.07M96.05M94.05M49.41M31.18M
Research and Development
61.54M73.12M75.66M40.36M26.00M
Selling, General, and Administrative Expenses
22.53M22.93M18.39M9.06M5.18M
Operating Income
-76.20M-90.32M-92.79M-49.18M-30.97M
Interest Income/Expense
7.00M2.22M280.00K200.00K520.00K
Other Income/Expense
N/A0.00-6.08M-11.75M-40.00K
Income Before Taxes
-69.20M-88.10M-98.59M-60.73M-30.49M
Net Income
-69.20M-88.10M-98.59M-60.73M-30.49M
EBITDA
-74.34M-88.65M-91.60M-48.57M-30.63M
 
Per Share Data
EPS Diluted Total Ops
-1.83-2.36-2.64-1.67-0.88
Non GAAP EPS
-1.83-2.36-3.14N/AN/A
 
Statistics
Profit Margin
-878.58%-1537.52%-7824.60%-26404.35%-13859.09%
Operating Profit Margin
-967.45%-1576.27%-7364.29%-21382.61%-14077.27%

All data in USD

Charts